Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Unicorn Foundation invited to speak at the first INCA/ENETs symposium

Unicorn Foundation invited to speak at the first INCA/ENETs symposium

  • January 18, 2017
On Friday 10th March the European Neuroendocrine Tumor Society (ENETS) and the International Neuroendocrine Cancer Alliance (INCA) will hold the first patient-physician symposium Unmet Needs in NET Care and Research: Priorities for Actions at the annual ENETS Scientific Meeting in Barcelona, Spain.

Unicorn Foundation CEO and INCA board member Simone Leyden has been invited to speak at the symposium on the "Unmet Needs" from the patient perspective. We are very grateful to ENETS President Prof Massimo Falconi and the advisory committee for their progressive view of including patients and patient groups within the highly respected ENETs program. This inclusion is reflective of the long and hard work of past and present INCA members and presidents and we are grateful to all those who have contributed over the years to make this possible.

We look forward to the meeting and reporting back to our UF friends on what the priorities will be moving forward, to better the outcomes for NET patients in Australia and around the world.

 

Share this post

Recent posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

February 9, 2026

Australia delivers excellent cancer care, but not equally

February 4, 2026

NECA Contributes to Multidisciplinary Systemic Review

January 28, 2026

AUS-NET Update, January 2026

January 20, 2026
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousThe loss of a true patient champion
NextAustralia’s National Patient & Carer Organisation Standing CommitteeNext

Related Posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Thank you to NET patient Kristen Leknius for hosting a neuroendocrine cancer information table at the February Peninsula Bays Hospital Wellness Day. With around 250

Australia delivers excellent cancer care, but not equally

Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer

AUS-NET Update, January 2026

The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,

CommNETs 2025

The 2025 CommNETs Annual Meeting was held in Vancouver on 5–6 December, bringing together neuroendocrine cancer specialists from across Commonwealth countries. CommNETs (Commonwealth Neuroendocrine Tumour

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin